Guangdong Bawei Biotechnology (BJSE:837023) EV-to-EBIT : 21.87 (As of Jun. 22, 2024)

Guangdong Bawei Biotechnology EV-to-EBIT Chart

Guangdong Bawei Biotechnology Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBIT		Get a 7-Day Free Trial					-	-	-	-	-

Guangdong Bawei Biotechnology Quarterly Data
	Jun17	Dec17	Mar18	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															-	-	-	-	29.60

Competitive Comparison of Guangdong Bawei Biotechnology's EV-to-EBIT

For the Household & Personal Products subindustry, Guangdong Bawei Biotechnology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guangdong Bawei Biotechnology's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Guangdong Bawei Biotechnology's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Guangdong Bawei Biotechnology's EV-to-EBIT falls into.

Guangdong Bawei Biotechnology EV-to-EBIT Calculation

Guangdong Bawei Biotechnology's EV-to-EBIT for today is calculated as:

Guangdong Bawei Biotechnology's current Enterprise Value is ¥1,074.4 Mil.
Guangdong Bawei Biotechnology's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥49.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong Bawei Biotechnology  (BJSE:837023) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Guangdong Bawei Biotechnology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Guangdong Bawei Biotechnology's Enterprise Value for the quarter that ended in Mar. 2024 was ¥1,454.2 Mil.
Guangdong Bawei Biotechnology's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥49.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong Bawei Biotechnology EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Guangdong Bawei Biotechnology's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong Bawei Biotechnology (BJSE:837023) Business Description